Resultados de búsqueda - Stéphane Chèze

  • Mostrando 1 - 15 Resultados de 15
Limitar resultados
  1. 1
    Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter study

    Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter study por Marc Michel, Marco Ruggeri, Tomás José González‐López, Salam Alkindi, Stéphane Chèze, Waleed Ghanima, Tor Henrik Anderson Tvedt, Mikaël Ebbo, Louis Terriou, James B. Bussel, Bertrand Godeau

    Publicado 2020
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  2. 2
    Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials

    Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within... por Céline Bossard, Karim Belhadj, Félix Reyes, Nadine Martin‐Garcia, Françoise Berger, J. Alain Kummer, Josette Brière, Anne–Catherine Baglin, Stéphane Chèze, Jacques Bosq, Vincent Ribrag, Christian Gisselbrecht, Nicolas Mounier, Philippe Gaulard

    Publicado 2006
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  3. 3
    Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study

    Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study por Bertrand Godeau, Raphaël Porcher, Olivier Fain, François Lefrère, Pierre Fenaux, Stéphane Chèze, Anne Vekhoff, Marie‐Paule Chauveheid, Jérôme Stirnemann, Lionel Galicier, Emmanuelle Bourgeois, Stéphanie Haïat, Bruno Varet, M Leporrier, T. Papo, Mehdi Khellaf, Marc Michel, Philippe Bierling

    Publicado 2008
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  4. 4
    Efficacy and safety of dapsone in adult primary immune thrombocytopenia

    Efficacy and safety of dapsone in adult primary immune thrombocytopenia por Marion Larue, Guillaume Moulis, Manuela Rueter, S. Audia, Louis Terriou, Jean‐François Viallard, Brigitte Pan‐Petesch, Bruno Royer, Bernard Bonnotte, Lionel Galicier, O. Lambotte, F. Lefrère, Stéphane Chèze, Mikaël Ebbo, T.A. Duong, Emmanuelle Boutin, Laetitia Languille, Matthieu Mahévas, Bertrand Godeau, Florence Canouï‐Poitrine, Marc Michel

    Publicado 2025
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  5. 5
    ASXL1 but Not TET2 Mutations Adversely Impact Overall Survival of Patients Suffering Systemic Mastocytosis with Associated Clonal Hematologic Non-Mast-Cell Diseases

    ASXL1 but Not TET2 Mutations Adversely Impact Overall Survival of Patients Suffering Systemic Mastocytosis with Associated Clonal Hematologic Non-Mast-Cell Diseases por Gandhi Damaj, Magalie Joris, Marie‐Olivia Chandesris, Katia Hanssens, Erinn Soucié, Danielle Canioni, Brigitte Kolb, I. Durieu, Emmanuel Gyan, C. Bulaï Livideanu, Stéphane Chèze, Momar Diouf, Réda Garidi, Sophie Georgin‐Lavialle, Vahid Asnafi, Ludovic Lhermitte, Christian Lavigne, David Launay, Michel Arock, Olivier Lortholary, Patrice Dubreuil, Olivier Hermine

    Publicado 2014
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  6. 6
    Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia

    Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia por Matthieu Mahévas, Mathieu Gerfaud‐Valentin, Guillaume Moulis, Louis Terriou, S. Audia, Sophie Guénin, G. Le Guenno, Gilles Salles, O. Lambotte, Nicolas Limal, Jean‐François Viallard, Stéphane Chèze, Cécile Tomowiak, Bruno Royer, A. Néel, O. Debouverie, A. Hot, I. Durieu, Antoinette Perlat, Manuel Cliquennois, Clémence Deteix, Marc Michel, Bertrand Godeau

    Publicado 2016
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  7. 7
    Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS?

    Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS? por Valeria Santini, Jennifer Schemenau, Alessandro Levis, Enrico Balleari, Rosa Sapena, Lionel Adès, Agnès Guerci, Odile Beyne‐Rauzy, Marie‐Pierre Gourin, Stéphane Chèze, Aspasia Stamatoullas, Alessandro Sanna, Daniela Gioia, Gianni Cametti, Dario Ferrero, Emmanuel Raffoux, Christian Rosé, Antonella Poloni, Thomas Prébet, Laurence Legros, Shanti Natarajan‐Amé, Pierre Fenaux, Ulrich Germing, François Dreyfus, Sophie Park

    Publicado 2013
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  8. 8
    Long‐term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP‐ritux

    Long‐term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP‐ritux por Samuel Deshayes, Mehdi Khellaf, Anissa Zarour, Richard Layese, O. Fain, Louis Terriou, Jean‐François Viallard, Stéphane Chèze, J. Graveleau, Borhane Slama, S. Audia, Manuel Cliquennois, Mikaël Ebbo, G. Le Guenno, Gilles Salles, Caroline Bonmati, F Teillet, Lionel Galicier, Olivier Lambotte, A. Hot, François Lefrère, Matthieu Mahévas, Florence Canouï‐Poitrine, Marc Michel, Bertrand Godeau

    Publicado 2019
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  9. 9
    Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use program

    Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use program por Mehdi Khellaf, Marc Michel, Philippe Quittet, Jean‐François Viallard, Magda Alexis, Françoise Roudot‐Thoraval, Stéphane Chèze, J.M. Durand, François Lefrère, Lionel Galicier, Olivier Lambotte, G. Panelatti, Borhane Slama, Gandhi Damaj, G Sébahoun, Emmanuel Gyan, X. Delbrel, Nathalie Dhédin, Bruno Royer, N. Schleinitz, Jean‐François Rossi, Matthieu Mahévas, Laetitia Languille, Philippe Bierling, Bertrand Godeau

    Publicado 2011
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  10. 10
    Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience

    Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience por Sophie Park, Sophie Grabar, Charikleia Kelaïdi, Odile Beyne‐Rauzy, Françoise Picard, Valérie Bardet, Valérie Coiteux, Geneviève Leroux, Pascale Lepelley, Marie‐Thérèse Daniel, Stéphane Chèze, Beatrice Mahé, Augustin Ferrant, Christophe Ravoet, Martine Escoffre‐Barbe, Lionel Adès, Norbert Vey, L. Aljassem, Aspasia Stamatoullas, Lionel Mannone, Hervé Dombret, Keith Bourgeois, Peter L. Greenberg, Pierre Fenaux, François Dreyfus

    Publicado 2007
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  11. 11
    Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients

    Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients por Mehdi Khellaf, Anaïs Charles‐Nelson, Olivier Fain, Louis Terriou, Jean‐François Viallard, Stéphane Chèze, J. Graveleau, Borhane Slama, S. Audia, Mikaël Ebbo, G. Le Guenno, Manuel Cliquennois, Gilles Salles, Caroline Bonmati, F Teillet, Lionel Galicier, A. Hot, Olivier Lambotte, François Lefrère, Salimatou Sacko, Dieudonné Kilendo Kengue, Philippe Bierling, Françoise Roudot‐Thoraval, Marc Michel, Bertrand Godeau

    Publicado 2014
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  12. 12
    Azacitidine in untreated acute myeloid leukemia: A report on 149 patients

    Azacitidine in untreated acute myeloid leukemia: A report on 149 patients por Sylvain Thépot, Raphaël Itzykson, Valérie Seegers, Christian Récher, Emmanuel Raffoux, Bruno Quesnel, Jacques Delaunay, Thomas Cluzeau, Anne Marfaing Koka, Aspasia Stamatoullas, Marie‐Pierre Chaury, Caroline Dartigeas, Stéphane Chèze, Anne Banos, Pierre Morel, Isabelle Plantier, Anne‐Laure Taksin, Jean Pierre Marolleau, Cécile Pautas, Xavier Thomas, Françoise Isnard, Blandine Bève, Yasmine Chaït, Agnès Guerci, Norbert Vey, François Dreyfus, Lionel Adès, Norbert Ifrah, Hervé Dombret, Pierre Fenaux, Claude Gardin

    Publicado 2013
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  13. 13
    BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders

    BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders por Frédérik Damm, Virginie Chesnais, Yasunobu Nagata, Kenichi Yoshida, Laurianne Scourzic, Yusuke Okuno, Raphaël Itzykson, Masashi Sanada, Yuichi Shiraishi, Véronique Gelsi‐Boyer, Aline Renneville, Satoru Miyano, Hiraku Mori, Lee‐Yung Shih, Sophie Park, François Dreyfus, Agnès Guerci‐Bresler, Éric Solary, Christian Rosé, Stéphane Chèze, Thomas Prébet, Norbert Vey, Marion Legentil, Yannis Duffourd, Stéphane de Botton, Claude Preudhomme, Daniel Birnbaum, Olivier Bernard, Seishi Ogawa, Michaëla Fontenay, Olivier Kosmider

    Publicado 2013
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  14. 14
    Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents

    Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents por Sophie Park, Jean-François Hamel, Andréa Toma, Charikleia Kelaïdi, Sylvain Thépot, María Díez‐Campelo, Valeria Santini, Mikkael A. Sekeres, Enrico Balleari, Jennifer Kaivers, Rosa Sapena, Katharina S. Götze, Catharina Müller‐Thomas, Odile Beyne‐Rauzy, Aspasia Stamatoullas, Ιoannis Kotsianidis, Rami S. Komrokji, David P. Steensma, Jaime Fensterl, Gail J. Roboz, Teresa Bernal, Fernando Ramos, Marisa Calabuig, Agnès Guerci‐Bresler, Dominique Bordessoule, Pascale Cony‐Makhoul, Stéphane Chèze, Eric Wattel, Christian Rosé, Norbert Vey, Daniela Gioia, Dario Ferrero, Gianluca Gaïdano, Giovanni Cametti, Fabrizio Pane, Alessandro Sanna, Ulrich Germing, Guillermo Sanz, François Dreyfus, Pierre Fenaux

    Publicado 2017
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  15. 15
    Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study

    Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study por S. Guillet, Étienne Crickx, Imane Azzaoui, Pascal Chappert, Emmanuelle Boutin, Jean‐François Viallard, Étienne Rivière, Delphine Gobert, Lionel Galicier, Marion Malphettes, Stéphane Chèze, François Lefrère, S. Audia, Bernard Bonnotte, Olivier Lambotte, Nicolas Noël, O. Fain, Guillaume Moulis, M. Hamidou, Mathieu Gerfaud‐Valentin, Jean‐Pierre Marolleau, Louis Terriou, Nihal Martis, Anne‐Sophie Morin, Antoinette Perlat, Thomas Le Gallou, F. Roy-Péaud, A. Robbins, Jean‐Christophe Lega, Mathieu Puyade, Thibault Comont, Nicolas Limal, Laetitia Languille, Anissa Zarour, Marine Luka, Mickaël Ménager, Thibaut Belmondo, Sophie Hüe, Florence Canouï‐Poitrine, Marc Michel, Bertrand Godeau, Matthieu Mahévas

    Publicado 2023
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:

Herramientas de búsqueda: